These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7115417)

  • 1. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT; Alcaraz AF; Schott HF
    Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine.
    Callaway CW; Kuczenski R; Segal DS
    Brain Res; 1989 Dec; 505(1):83-90. PubMed ID: 2611681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]dopamine depletion from osmotically defined storage sites: effects of reserpine, 53 mM KCl, and d-amphetamine.
    Takimoto GS; Stittsworth JD; Stephens JK
    J Neurochem; 1983 Jul; 41(1):119-27. PubMed ID: 6864214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lability in storage of 3H-dopamine and 3H-norepinephrine in crude synaptosome (P2) and vesicle-associated fractions of rat brain.
    Bianchi BR; Takimoto GS
    Life Sci; 1984 Feb; 34(7):607-15. PubMed ID: 6700371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis.
    Sabol KE; Seiden LS
    Brain Res; 1998 Sep; 806(1):69-78. PubMed ID: 9739110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic effects of amphetamine on striatal dopamine dynamics.
    Kuczenski R
    Eur J Pharmacol; 1977 Dec; 46(3):249-57. PubMed ID: 590334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools.
    Kuczenski R
    J Pharmacol Exp Ther; 1977 May; 201(2):357-67. PubMed ID: 870679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes.
    Bowyer JF; Masserano JM; Weiner N
    J Pharmacol Exp Ther; 1987 Jan; 240(1):177-86. PubMed ID: 3100768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):1-5. PubMed ID: 882144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine.
    Miller HH; Shore PA
    Eur J Pharmacol; 1982 Feb; 78(1):33-44. PubMed ID: 6122585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.
    Niddam R; Arbilla S; Scatton B; Dennis T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):123-7. PubMed ID: 4010791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine synthesis in synaptosomes: relation of autoreceptor functioning to pH, membrane depolarization, and intrasynaptosomal dopamine content.
    Saller CF; Salama AI
    J Neurochem; 1984 Sep; 43(3):675-88. PubMed ID: 6747629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of amineptine with the neuronal dopamine uptake system: neurochemical in vitro and in vivo studies.
    Bonnet JJ; Chagraoui A; Protais P; Costentin J
    J Neural Transm; 1987; 69(3-4):211-20. PubMed ID: 3625193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a similar compartmentation of recaptured and endogenously synthesized dopamine in striatal synaptosomes.
    Cerrito F; Casazza G; Levi G; Raiteri M
    Neurochem Res; 1980 Feb; 5(2):115-21. PubMed ID: 7366797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microassay for measuring synaptosomal 3H-dopamine and 3H-metabolite release.
    Petrie EC; Lombrozo L; Csernansky JG
    Brain Res Bull; 1990 Sep; 25(3):423-7. PubMed ID: 2292040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.